'Delisting' OxyContin® to reduce prescription opioid-related harms in Ontario (Canada)-gauging effects 5 years later.

about

'Delisting' OxyContin® to reduce prescription opioid-related harms in Ontario (Canada)-gauging effects 5 years later.

Item

http://www.wikidata.org/entity/Q44347129

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

'Delisting' OxyContin® to redu ...... gauging effects 5 years later.

@en

'Delisting' OxyContin® to reduce prescription opioid-related harms in Ontario

@nl

type

Item

label

'Delisting' OxyContin® to redu ...... gauging effects 5 years later.

@en

'Delisting' OxyContin® to reduce prescription opioid-related harms in Ontario

@nl

prefLabel

'Delisting' OxyContin® to redu ...... gauging effects 5 years later.

@en

'Delisting' OxyContin® to reduce prescription opioid-related harms in Ontario

@nl

P1476

'Delisting' OxyContin® to redu ...... gauging effects 5 years later.

@en

P2093

Lenka Vojtila

http://www.w3.org/2001/XMLSchema#string

Paul Kurdyak

http://www.w3.org/2001/XMLSchema#string

P2860

CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Guideline for opioid therapy and chronic noncancer pain.

Tamper-resistant drugs cannot solve the opioid crisis

Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.

Treatment of prescription opioid disorders in Canada: looking at the 'other epidemic'?

Reductions in non-medical prescription opioid use among adults in Ontario, Canada: are recent policy interventions working?

Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.

The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature.

Current approaches in tamper-resistant and abuse-deterrent formulations.

Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?

P304

1040-1043

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.4253

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

B Fischer

P577

2017-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28691404

http://www.w3.org/2001/XMLSchema#string